Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aerie Pharmaceuticals, Inc. - Common Stock
(NQ:
AERI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 18, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Aerie Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
Next >
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
November 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
October 14, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
October 04, 2022
Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.
Via
MarketBeat
Topics
Stocks
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options
September 13, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
August 24, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
AERI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Aerie Pharmaceuticals, Inc. Is Fair to Shareholders
August 24, 2022
From
Halper Sadeh LLP
Via
Business Wire
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
August 23, 2022
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of
Via
Spotlight Growth
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
August 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Aerie Pharmaceuticals Announces New Employee Inducement Grant
August 15, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
August 04, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Treatment of Dry Eye Disease
August 01, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on Thursday, August 4, 2022 at 5:00 p.m. ET
July 28, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Announces New Employee Inducement Grant
July 08, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET
May 25, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease
May 24, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
May 05, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022 at 5:00 p.m. ET
April 28, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Announces Presentations at the Association for Research in Vision and Ophthalmology Annual Meeting in Denver, Colorado, May 1-4, 2022
April 26, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2022) in Washington, D.C., April 22-26, 2022
April 20, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 3:00 p.m. ET
April 06, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer
March 18, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
February 24, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Appoints Gary Sternberg, M.D., M.B.A. as Chief Medical Officer
February 24, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022 at 5:00 p.m. ET
February 17, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Reports Inducement Grant to Chief Executive Officer Under Nasdaq Listing Rule 5635(c)(4)
December 22, 2021
From
Aerie Pharmaceuticals
Via
Business Wire
Aerie Pharmaceuticals Appoints Raj Kannan as Chief Executive Officer
December 16, 2021
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions
December 07, 2021
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences
November 09, 2021
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Aerie Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
November 04, 2021
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
